Founded in 1989 to solve the "unsolvable problem" of accurate pulse oximetry during patient movement, Masimo (NASDAQ:MASI) develops and manufactures noninvasive patient monitoring technologies, ...

A continuous glucose monitor (CGM) can tell you when my glucose spikes, but not that I delayed correcting it because I was in a high-stakes meeting. It can record the number after I under-bolused for ...

All right. Good morning, everyone, and welcome to Masimo's 2025 Investor Day. I'm Matt Brinckman. I recently joined Masimo as Senior Vice President of FP&A and Investor Relations. I've been working ...

Shares of medical tech company Masimo (NASDAQ:MASI) jumped 3.5% in the morning session after the company presented an upbeat long-term financial outlook at its 2025 Investor Day, prompting positive ...

A new advancement in blood pressure (BP) monitoring could streamline efforts for continuous tracking. Despite progress in wearable medical technology, measuring BP relies on cuff-based monitoring.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Masimo (NASDAQ:MASI) and the best and worst ...

I peered dubiously at the plastic disc in my hand, with its little needle protruding from the centre. I have no major beef with needles, but this was different – I had to somehow find the gumption to ...